Genomic insights into influenza A(H1N1)pdm09 virus evolution in Yunnan province, China, during 2018-2023.

Publication date: Jul 03, 2026

Research on regional circulation and evolution of influenza A viruses before and after the COVID-19 pandemic is crucial for informing vaccine updates and antiviral drug development. This study generated 260 new genomic sequences of influenza A(H1N1)pdm09 viruses collected in Yunnan province, China, between 2018 and 2023. Comparative genomics analyses elucidated their evolutionary characteristics and dynamics. Epidemiological analysis identified key risk factors (sex, age, occupation) for influenza infection. Phylogenetic analyses revealed the sequence divergences between the vaccine strains and Yunnan circulating strains, especially in the 2020-2024 influenza seasons. The subclade reassortment events were extremely limited among these sequenced Yunnan strains, suggesting the reassortment may be not a major contributor for the circulation and evolution of influenza A(H1N1)pdm09 viruses in Yunnan during these influenza seasons. We detected the elevated evolutionary pressures acting on the specific gene segments, reflected in increased d/d ratios, particularly for envelope proteins. Furthermore, numerous amino acid substitutions (e. g., S185I/T) within HA antigenic epitopes and receptor binding sites were identified in most Yunnan strains, indicating potential roles of antigenic drift in modulating viral antigenicity and host adaptation. Notably, 17 amino acid substitutions in HA and NA (including HA: N156K) accumulated to higher frequencies during the 2022-2023 and 2023-2024 seasons. These changes likely represented the molecular signature of contemporary A(H1N1)pdm09 viruses in Yunnan. Collectively, this study explored the molecular evolutionary dynamics of A(H1N1)pdm09 viruses in Yunnan province during diverse influenza seasons, providing new regional data for studying molecular characterization and evolution of A(H1N1)pdm09 within the global surveillance framework.

Open Access PDF

Concepts Keywords
Adaptation
Evolutionary characteristics
Reassortment
Yunnan province

Semantics

Type Source Name
pathway KEGG Influenza A
disease MESH COVID-19 pandemic
pathway REACTOME Influenza Infection
disease MESH strains
disease MESH influenza
pathway REACTOME Reproduction
disease MESH included
disease MESH Infectious Diseases
pathway REACTOME Apoptosis
disease MESH viral infection
disease MESH infections
drug DRUGBANK Isoxaflutole
drug DRUGBANK Amino acids
disease MESH NS1
drug DRUGBANK Oseltamivir
drug DRUGBANK Zanamivir
drug DRUGBANK Peramivir
drug DRUGBANK Laninamivir
drug DRUGBANK Amantadine
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Adamantane
pathway REACTOME Autophagy
pathway KEGG Viral replication
drug DRUGBANK Baloxavir marboxil
disease MESH fever
disease MESH cough
disease MESH PBS
drug DRUGBANK Streptomycin
drug DRUGBANK Trypsin
drug DRUGBANK L-Aspartic Acid
disease MESH FEL
disease MESH CAS
drug DRUGBANK Bean
disease MESH Dis
drug DRUGBANK Carboxyamidotriazole
drug DRUGBANK Diethylstilbestrol
disease MESH Des
drug DRUGBANK Guanosine
pathway REACTOME Mitophagy
disease MESH cap
drug DRUGBANK L-Asparagine

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *